274 genotypes with 300 annotations displayed
of selected term and subterms
|
Searched Term: increased leukemia incidence
|
Aicdatm1(cre)Mnz/Aicda+ Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased leukemia incidence
|
J:153656
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
increased acute lymphoblastic leukemia incidence
|
J:193232
|
Alox15tm1Fun/Alox15tm1Fun
(B6.129S2-Alox15tm1Fun/J)
|
increased chronic myelocytic leukemia incidence
|
J:119405
|
Arid4atm1Alb/Arid4atm1Alb
(involves: 129S7/SvEvBrd)
|
increased leukemia incidence
|
J:141004
|
Arid4atm1Alb/Arid4atm1Alb Arid4btm1Alb/Arid4b+
(involves: 129S7/SvEvBrd)
|
increased leukemia incidence
|
J:141004
|
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6)
|
increased leukemia incidence
|
J:208085
|
Atmtm1Mfl/Atm+
(involves: 129T2/SvEms * C57BL/6J)
|
increased leukemia incidence
|
J:78527
|
Bap1tm1.1Geno/Bap1tm1.1Geno Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased leukemia incidence
|
J:187380
|
Blnktm1Dkit/Blnktm1Dkit
(involves: C57BL/6)
|
increased leukemia incidence
|
J:84040
|
Blnktm1Dkit/Blnktm1Dkit Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
increased leukemia incidence
|
J:84040
|
Braftm1Cpri/Braf+ Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:104375
|
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6)
|
increased leukemia incidence
|
J:201641
|
Cd3etm1Mal/Cd3etm1Mal Tg(Tcrb-TCF3/PBX1)23Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased acute lymphoblastic leukemia incidence
|
J:95693
|
increased leukemia incidence
|
J:95693
|
Cd19tm1(cre)Cgn/Cd19+ Mirc30tm1.1Rdf/Mirc30tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased leukemia incidence
|
J:156946
|
Cd19tm1(cre)Cgn/Cd19+ Ptpn11tm1Ckq/Ptpn11+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
increased acute lymphoblastic leukemia incidence
|
J:177285
|
Cdkn2aem1Cjs/Cdkn2aem1Cjs
(B6.Cg-Cdkn2aem1Cjs)
|
increased acute lymphoblastic leukemia incidence
|
J:244260
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6)
|
increased acute lymphoblastic leukemia incidence
|
J:244260
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Sclt1Tg(CAG-sb10)1Dla/0 TgTn(sb-T2/Onc)68Dla/0
(involves: 129X1/SvJ * FVB/N)
|
increased leukemia incidence
|
J:99991
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Sclt1Tg(CAG-sb10)1Dla/0 TgTn(sb-T2/Onc)76Dla/0
(involves: 129X1/SvJ * FVB/N)
|
increased leukemia incidence
|
J:99991
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased leukemia incidence
|
J:131914
|
Cdkn2atm2Brn/Cdkn2a+ Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:132943
|
Cdkn2atm2Brn/Cdkn2atm2Brn Nf2tm2Gth/Nf2+
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:132943
|
Cdkn2atm2Brn/Cdkn2atm2Brn Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:132943
|
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased leukemia incidence
|
J:136134
|
Chordc1tm1Mbra/Chordc1+
(involves: 129 * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:222040
|
Col1a1tm1(CAG-Mir22)Ppp/Col1a1tm1(CAG-Mir22)Ppp Tg(Mx1-cre)1Cgn/0
(Not Specified)
|
increased leukemia incidence
|
J:199366
|
Col1a1tm2(tetO-IDH2*R140Q)Ppp/Col1a1tm2(tetO-IDH2*R140Q)Ppp Flt3tm1.1Dosm/Flt3tm1.1Dosm Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129 * C57BL/6)
|
increased leukemia incidence
|
J:210097
|
Col1a1tm2(tetO-IDH2*R140Q)Ppp/Col1a1tm2(tetO-IDH2*R140Q)Ppp Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6)
|
increased leukemia incidence
|
J:210097
|
Col1a1tm3(tetO-GFP/RNAi:Apc)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
increased leukemia incidence
|
J:171191
|
Col1a1tm4(tetO-GFP/RNAi:Apc)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
increased leukemia incidence
|
J:171191
|
Col1a1tm6(tetO-MSI2)Jae/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
increased leukemia incidence
|
J:163322
|
Crebbptm1Dli/Crebbp+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased leukemia incidence
|
J:60630
|
Crkltm1Hkp/Crkltm1Hkp Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:76680
|
Ctsgtm1Ley/Ctsgtm2.1(PML/RARA)Ley
(involves: 129X1/SvJ * C57BL/6)
|
increased leukemia incidence
|
J:84230
|
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
(involves: 129X1/SvJ * C57BL/6)
|
increased leukemia incidence
|
J:84230,
J:86458
|
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
(involves: 129 * 129X1/SvJ * C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:166479
|
Ctsgtm2.1(PML/RARA)Ley/Ctsg+ Elanetm1Sds/Elanetm1Sds
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
increased leukemia incidence
|
J:86458
|
Ctsgtm2.1(PML/RARA)Ley/Ctsgtm2.1(PML/RARA)Ley
(involves: 129X1/SvJ * C57BL/6)
|
increased leukemia incidence
|
J:84230
|
Ctsgtm3.1(PML/RARA)Ley/Ctsg+
(involves: 129 * C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:166479
|
Del(4Cdkn2a-Cdkn2b)1Brn/+
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:125189
|
Del(4Cdkn2a-Cdkn2b)2Brn/+
(involves: 129P2/OlaHsd * FVB/N)
|
increased leukemia incidence
|
J:125189
|
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased leukemia incidence
|
J:156946
|
Del(14Trim13-Rnaseh2b)6Rdf/+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:179879
|
Dicer1tm1Mmk/Dicer1tm1Mmk Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
increased leukemia incidence
|
J:158901
|
Dnmt1tm1(tetO-BCL2)Sjk/Dnmt1+ Tg(IghMyc)22Bri/0 Tg(MMTVtTA)1Mam/0
(involves: 129S4/SvJae * C57BL/6)
|
increased leukemia incidence
|
J:93549
|
Dok1tm1Ppp/Dok1+ Tg(Tec-BCR/ABL1)5Hhi/0
(involves: 129S1/Sv)
|
increased leukemia incidence
|
J:95334
|
Dok1tm1Ppp/Dok1tm1Ppp Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp)
|
increased leukemia incidence
|
J:95334
|
Dok1tm1Ppp/Dok1tm1Ppp Dok2tm1Ppp/Dok2tm1Ppp Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp Dok3tm1Ppp)
|
increased chronic myelocytic leukemia incidence
|
J:158011
|
Dok1tm1Ppp/Dok1tm1Ppp Tg(Tec-BCR/ABL1)5Hhi/0
(involves: 129S1/Sv)
|
increased leukemia incidence
|
J:95334
|
Dok1tm1Yyam/Dok1tm1Yyam Dok2tm1Yyam/Dok2tm1Yyam
(B6.129-Dok1tm1Yyam Dok2tm1Yyam)
|
increased leukemia incidence
|
J:95335
|
Dok1tm1Yyam/Dok1tm1Yyam Dok2tm1Yyam/Dok2tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6)
|
increased leukemia incidence
|
J:95335
|
Dok1tm1Yyam/Dok1tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6)
|
increased leukemia incidence
|
J:95335
|
Dok2tm1Ppp/Dok2+ Tg(Tec-BCR/ABL1)5Hhi/0
(involves: 129S1/Sv)
|
increased leukemia incidence
|
J:95334
|
Dok2tm1Ppp/Dok2tm1Ppp Tg(Tec-BCR/ABL1)5Hhi/0
(involves: 129S1/Sv)
|
increased leukemia incidence
|
J:95334
|
Dok2tm1Yyam/Dok2tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6)
|
increased leukemia incidence
|
J:95335
|
Eef1a1tm2Arge/Eef1a1+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:197167
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased chronic myelocytic leukemia incidence
|
J:83617
|
Etv6tm1(RUNX1)Haho/Etv6+ Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:151639
|
Etv6tm1.1(RUNX1,hsb5)Lvdw/Etv6+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J)
|
increased leukemia incidence
|
J:174866
|
Etv6tm1.1(RUNX1,hsb5)Lvdw/Etv6+ TgTn(sb-T2/Onc)76Dla/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
increased leukemia incidence
|
J:174866
|
Etv6tm3(NTRK3)Sho/Etv6+ Tg(MMTV-cre)FMam/0
(involves: 129S1/Sv * FVB/N)
|
increased chronic myelocytic leukemia incidence
|
J:130323
|
Ewsr1tm1(ERG)Thr/Ewsr1+ Rag1tm1(cre)Thr/Rag1+
(involves: 129S/SvEv)
|
increased leukemia incidence
|
J:98679
|
Ezh2tm1.1Nesh/Ezh2+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased leukemia incidence
|
J:239472
|
Ezh2tm2Sho/Ezh2tm2.1Sho Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:182211
|
Ezh2tm2Sho/Ezh2tm2Sho Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:182211
|
Fli1tm1Ber/Fli1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased leukemia incidence
|
J:33052
|
Fli1tm1Ber/Fli1tm1Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased leukemia incidence
|
J:33052
|
Flt3tm1Dgg/Flt3+ Kmt2atm1Clgr/Kmt2a+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
increased leukemia incidence
|
J:189096
|
Flt3tm1Dgg/Flt3tm1Dgg Kmt2atm1Clgr/Kmt2a+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
increased leukemia incidence
|
J:189096
|
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6)
|
increased leukemia incidence
|
J:193993
|
Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:129039
|
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sortm9(cre/ESR1)Arte Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6)
|
increased acute lymphoblastic leukemia incidence
|
J:170965
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:167000
|
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+ TgTn(pb-sb-ATP2)H27Brd/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased leukemia incidence
|
J:166063
|
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+ TgTn(pb-sb-ATP2)H32Brd/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased leukemia incidence
|
J:166063
|
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+ TgTn(pb-sb-ATP2)S1Brd/0
(involves: 129S7/SvEvBrd * FVB)
|
increased leukemia incidence
|
J:166063
|
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+ TgTn(pb-sb-ATP2)S2Brd/0
(involves: 129S7/SvEvBrd * FVB)
|
increased leukemia incidence
|
J:166063
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
increased acute lymphoblastic leukemia incidence
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:202090
|
Gt(ROSA)26Sortm2.1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
increased leukemia incidence
|
J:153656
|
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+ Npm1tm1Gsva/Npm1+ TgTn(pb-sb-GrOnc)#aGsva/0 Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased acute promyelocytic leukemia incidence
|
J:172071
|
increased leukemia incidence
|
J:172071
|
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0 Tg(Tal1-tTA)19Dgt/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N)
|
increased chronic myelocytic leukemia incidence
|
J:227558
|
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J * FVB/N)
|
increased leukemia incidence
|
J:227558
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6)
|
increased acute lymphoblastic leukemia incidence
|
J:170965
|
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sortm18(Zeb2)Jhai Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
increased T cell acute lymphoblastic leukemia incidence
|
J:263520
|
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sortm18(Zeb2)Jhai Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * CD-1 * SJL)
|
increased T cell acute lymphoblastic leukemia incidence
|
J:263520
|
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sortm18(Zeb2)Jhai Tg(Tek-cre)1Ywa/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
increased leukemia incidence
|
J:263520
|
Hip1tm4Tsr/Hip1+ Runx1tm3Dow/Runx1+ Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:151974
|
Hmga1tm1Afus/Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased leukemia incidence
|
J:106702
|
Hrhr/Hrhr
(HRS/J)
|
increased leukemia incidence
|
J:5726,
J:5908,
J:24786
|
Ightm1.1(Tag)Rwhe/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:150315
|
increased leukemia incidence
|
J:150315
|
Ightm1.1(Tag)Rwhe/Igh+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:150315
|
increased leukemia incidence
|
J:150315
|
Ightm2.1(Tag)Rwhe/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:150315
|
increased leukemia incidence
|
J:150315
|
Ightm2.1(Tag)Rwhe/Igh+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:150315
|
increased leukemia incidence
|
J:150315
|
Ighatm1(Myc)Janz/Igha+ Tg(Igk-V21-Bax)1967Bvn/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased leukemia incidence
|
J:90901
|
Ighatm1(Myc)Janz/Igha+ Tg(Tnfsf13b)1Fma/0
(involves: 129S1/Sv * C57BL/6 * DBA/2J)
|
increased chronic lymphocytic leukemia incidence
|
J:166158
|
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc)
|
increased leukemia incidence
|
J:84569
|
Ikzf1tm1Kast/Ikzf1+ Tg(BCR/ABL)623Hkp/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:160846
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
increased leukemia incidence
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
increased leukemia incidence
|
J:29355
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1r
(BXH2/TyJ)
|
increased chronic myelocytic leukemia incidence
|
J:97931
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1r
(involves: A/J * BXH2/TyJ)
|
increased chronic myelocytic leukemia incidence
|
J:97931
|
Irf8tm1Hor/Irf8+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased chronic myelocytic leukemia incidence
|
J:36038
|
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased chronic myelocytic leukemia incidence
|
J:36038
|
Is(14)1Rdf Is(14)2Rdf/Del(14Trim13-Dleu2)4Rdf Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased leukemia incidence
|
J:156946
|
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:179879
|
Is(14)1Rdf/Is(14)1Rdf Is(14)5Rdf/Is(14)5Rdf Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased chronic lymphocytic leukemia incidence
|
J:179879
|
Jak2tm1(JAK2)Argr/Jak2+ Dppa3tm1(cre)Peli/Dppa3+
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:233169
|
Junbtm3Wag/Junbtm3Wag Meox2tm1(cre)Sor/Meox2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:88126
|
Kdm6atm1Cdcn/Y Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:263565
|
Kdm6atm1Cdcn/Y Tg(CAG-cre/Esr1*)5Amc/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J * CBA * FVB/N)
|
increased chronic myelocytic leukemia incidence
|
J:263565
|
Kdm6atm1Cdcn/Kdm6atm1Cdcn Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:263565
|
KitlSl/KitlSl-d
(involves: C57BL/6 * WC)
|
increased leukemia incidence
|
J:5758
|
Kmt2atm1(AFF1)Ksy/Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB)
|
increased leukemia incidence
|
J:110241
|
Kmt2atm1(MLL1/ERT)Divo/?
(involves: 129S4/SvJae * C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:189329
|
Kmt2atm1.1(Sh3gl1)Lcc/Kmt2a+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased leukemia incidence
|
J:205605
|
Kmt2atm1Saam/Kmt2a+ Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:140628
|
Kmt2atm1Thr/Kmt2a+ Mllt3tm2Thr/Mllt3+ Tg(Lck-cre)1Thr/?
(involves: 129S/SvEv)
|
increased leukemia incidence
|
J:100794
|
Kmt2atm2(MLLT3)Thr/Kmt2a+
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:56340
|
Kmt2atm2(MLLT3)Thr/Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased leukemia incidence
|
J:110241
|
Krastm4Tyj/Kras+ Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
increased leukemia incidence
|
J:247853
|
Lmo2tm2(cre)Thr/Lmo2+ Kmt2atm1Thr/Kmt2a+ Mllt1tm1Thr/Mllt1+
(involves: 129S/SvEv)
|
increased leukemia incidence
|
J:84518,
J:100794
|
Mcm2Gt(AB0178)Wtsi/Mcm2+ Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
increased leukemia incidence
|
J:165667
|
Mcm4Sdla/Mcm4+
(involves: C57BL/6)
|
increased acute lymphoblastic leukemia incidence
|
J:194117
|
Mirc30em1Hhzg/Mirc30em1Hhzg Tg(Vav1-cre)#Cgp/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)
|
increased chronic lymphocytic leukemia incidence
|
J:320883
|
Mirc30tm1.2Rdf/Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased leukemia incidence
|
J:156946
|
Mleu1SWR/J/? Tg(CTSG-PML/RARA)135Ley/0
(involves: C3H/HeJ * C57BL/6J * SWR/J)
|
increased leukemia incidence
|
J:139159
|
Mleu2SWR/J/? Tg(CTSG-PML/RARA)135Ley/0
(involves: C3H/HeJ * C57BL/6J * SWR/J)
|
increased leukemia incidence
|
J:139159
|
Mleu3C57BL/6J/Mleu3SWR/J Tg(CTSG-PML/RARA)135Ley/0
(involves: C3H/HeJ * C57BL/6J * SWR/J)
|
increased leukemia incidence
|
J:139159
|
Mleu4SWR/J/? Tg(CTSG-PML/RARA)135Ley/0
(involves: C3H/HeJ * C57BL/6J * SWR/J)
|
increased leukemia incidence
|
J:139159
|
Mleu5SWR/J/? Tg(CTSG-PML/RARA)135Ley/0
(involves: C3H/HeJ * C57BL/6J * SWR/J)
|
increased leukemia incidence
|
J:139159
|
Mtbptm1Glo/Mtbp+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J)
|
increased leukemia incidence
|
J:135509
|
Mybl2tm1.1Jof/Mybl2+ Tg(Zp3-cre)3Mrt/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
increased leukemia incidence
|
J:196804
|
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased leukemia incidence
|
J:195140
|
Nbnem7Jpt/Nbntm2Zqw Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
increased T cell acute lymphoblastic leukemia incidence
|
J:277750
|
Ncstntm1.1Akli/Ncstntm1.1Akli Tet2tm1.1Iaai/Tet2tm1.1Iaai Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
increased leukemia incidence
|
J:196407
|
Ncstntm1.1Akli/Ncstntm1.1Akli Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
increased leukemia incidence
|
J:172442
|
Ncstntm1.1Akli/Ncstntm1.1Akli Tg(VAV1-cre)1Graf/0
(involves: 129 * C57BL/6 * SJL)
|
increased leukemia incidence
|
J:172442
|
Nf1tm1Fcr/Nf1+ Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Nf1tm1Fcr Ptentm1Hwu)
|
increased T cell acute lymphoblastic leukemia incidence
|
J:232645
|
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6)
|
increased leukemia incidence
|
J:18542
|
Nf2tm2Gth/Nf2+ Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased leukemia incidence
|
J:132943
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased leukemia incidence
|
J:132943
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased leukemia incidence
|
J:132943
|
Nfe2tm1.1Hlpa/?
(involves: 129 * C57BL/6)
|
increased acute myeloid leukemia incidence
|
J:275444
|
Notch1tm2Rko/Notch1tm2Rko Notch2tm1Rko/Notch2tm1Rko Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:172442
|
Npm1tm1Gsva/Npm1+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased acute promyelocytic leukemia incidence
|
J:172071
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
increased leukemia incidence
|
J:121903
|
Nrastm1Tyj/Nrastm1Tyj Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:204263
|
Nrbp1tm1.1Dja/Nrbp1tm1.1Dja Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J)
|
increased leukemia incidence
|
J:184685
|
Nrbp1tm1.1Dja/Nrbp1tm1.2Dja Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J)
|
increased leukemia incidence
|
J:184685
|
Pax5tm3Mbu/Pax5+ Tcf3tm1(PBX1)Mlc/Tcf3+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell acute lymphoblastic leukemia incidence
|
J:226241
|
Phf6tm1.1Avo/Y Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
increased leukemia incidence
|
J:276228
|
Phf6tm1.2Avo/Phf6+
(involves: BALB/cJ * C57BL/6)
|
increased leukemia incidence
|
J:276228
|
Pkn3tm1.1Mrl/Pkn3+ Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
increased acute lymphoblastic leukemia incidence
|
J:216983
|
Pkn3tm1.1Mrl/Pkn3tm1.1Mrl Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
increased acute lymphoblastic leukemia incidence
|
J:216983
|
Pmltm1(PML/RARA)Ley/Pml+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased leukemia incidence
|
J:172024
|
Pmltm1.1Ews/Pmltm1.1Ews Tg(PML-RARA)556Kog/0
(FVB.Cg-Pmltm1.1Ews Tg(PML-RARA)556Kog)
|
increased acute promyelocytic leukemia incidence
|
J:262172
|
Ptentm1Hwu/Ptentm1Hwu Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:169097
|
Ptentm1Hwu/Ptentm1Hwu Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N)
|
increased acute lymphoblastic leukemia incidence
|
J:135172
|
increased acute promyelocytic leukemia incidence
|
J:135172
|
Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:169097
|
Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(BKS.Cg-Ptprcb Thy1a Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
increased acute lymphoblastic leukemia incidence
|
J:109085
|
increased acute promyelocytic leukemia incidence
|
J:109085
|
increased leukemia incidence
|
J:109085
|
Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
increased T cell acute lymphoblastic leukemia incidence
|
J:232645
|
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased leukemia incidence
|
J:50437
|
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J)
|
increased leukemia incidence
|
J:53065
|
Ptpn11tm1Ckq/Ptpn11+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
increased acute promyelocytic leukemia incidence
|
J:177285
|
Ptpn11tm1Ckq/Ptpn11+ Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased acute lymphoblastic leukemia incidence
|
J:177285
|
Ptpn11tm1Ckq/Ptpn11+ Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:177285
|
increased acute promyelocytic leukemia incidence
|
J:177285
|
increased leukemia incidence
|
J:177285
|
Rac3tm1Hkp/Rac3tm1Hkp Tg(BCR/ABL)623Hkp/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
increased leukemia incidence
|
J:99168
|
Rad50tm2Jpt/Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
increased leukemia incidence
|
J:78820
|
Rbm15tm1.1(MAL)Dgg/Rbm15tm1.1(MAL)Dgg
(B6.129-Rbm15tm1.1(MAL)Dgg)
|
increased leukemia incidence
|
J:149622
|
Rgsc142/Rgsc142+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased leukemia incidence
|
J:133634
|
Rgv1C57BL/6/Rgv1C57BL/6
(involves: C3Hf/Bi * C57BL/6)
|
increased leukemia incidence
|
J:5011
|
Rigitm1Zgwg/Rigitm1Zgwg
(involves: 129S1/Sv)
|
increased chronic myelocytic leukemia incidence
|
J:139016
|
Ril1A/J/Ril1A/J
(involves: A/J * C57BL/10ScSn)
|
increased leukemia incidence
|
J:6610
|
Ril1A/J/Ril1C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
increased leukemia incidence
|
J:6610
|
Ril2A/J/Ril2C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
increased leukemia incidence
|
J:6610
|
Ril2C57BL/10ScSn/Ril2C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
increased leukemia incidence
|
J:6610
|
Ril3A/J/Ril3C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
increased leukemia incidence
|
J:6610
|
Ril3C57BL/10ScSn/Ril3C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
increased leukemia incidence
|
J:6610
|
Ril4BALB/c/Ril4BALB/c
(B6.C-H30c/(HW105)ByJ)
|
increased leukemia incidence
|
J:7027
|
Runx1tm3Dow/Runx1+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased acute promyelocytic leukemia incidence
|
J:77129
|
Rv2BALB/cJ/Rv2BALB/cJ
(B6.C-H7b/By)
|
increased leukemia incidence
|
J:7613
|
Rv2BALB/cJ/Rv2BALB/cJ
(B10.C-H7b/(47N)SnJ)
|
increased leukemia incidence
|
J:7613
|
Rv3C57BL/6J/Rv3C57BL/6J
(involves: C57BL/6J * CBA/Lac)
|
increased leukemia incidence
|
J:7613
|
Rv3C57BL/6J/Rv3CBA/Lac
(involves: C57BL/6J * CBA/Lac)
|
increased leukemia incidence
|
J:7613
|
Rv3CBA/Lac/Rv3CBA/Lac
(involves: C57BL/6J * CBA/Lac)
|
increased leukemia incidence
|
J:7613
|
Rvil1CE/J/Rvil1CE/J
(B10.CE-H3bb/(30NX)SnDcr)
|
increased leukemia incidence
|
J:7027
|
Samd9ltm1Homy/Samd9l+
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:180923,
J:202604
|
Samd9ltm1Homy/Samd9ltm1Homy
(involves: 129P2/OlaHsd)
|
increased leukemia incidence
|
J:180923,
J:202604
|
Samd9ltm1Homy/Samd9ltm1Homy
(B6N.129P2-Samd9ltm1Homy)
|
increased leukemia incidence
|
J:225110
|
Sipa1tm1Nm/Sipa1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:97239
|
Sipa1tm1Nm/Sipa1tm1Nm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:97239
|
Smap1tm1.1Sata/Smap1tm1.1Sata
(B6.Cg-Smap1tm1.1Sata)
|
increased leukemia incidence
|
J:196385
|
Soat1ald/Soat1ald
(AKR/O)
|
increased leukemia incidence
|
J:12157
|
Spi1tm1.1Dgt/Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ)
|
increased leukemia incidence
|
J:90331
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
increased leukemia incidence
|
J:106040
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6)
|
increased leukemia incidence
|
J:90331
|
Tcf3tm1(PBX1)Mlc/Tcf3+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell acute lymphoblastic leukemia incidence
|
J:226241
|
Tcf3tm1(PBX1)Mlc/Tcf3+ Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
increased B cell acute lymphoblastic leukemia incidence
|
J:226241
|
Tcf3tm1(PBX1)Mlc/Tcf3+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J)
|
increased B cell acute lymphoblastic leukemia incidence
|
J:226241
|
Tcf3tm1(TCF3/HLF)Homy/Tcf3+ Tg(Emu-Zfp521)1Homy/0 Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:160392
|
Tet2tm1.1Iaai/Tet2tm1.1Iaai Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:174053
|
Tet2tm1.1Mjxu/Tet2+
(involves: 129 * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:178415
|
increased leukemia incidence
|
J:178415
|
Tet2tm1.1Mjxu/Tet2tm1.1Mjxu
(involves: 129 * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:178415
|
increased leukemia incidence
|
J:178415
|
Tg(BCL2)36Wehi/0 Tg(IghMyc)22Bri/0
(B6.Cg-Tg(BCL2)36Wehi Tg(IghMyc)22Bri)
|
increased B cell acute lymphoblastic leukemia incidence
|
J:354285
|
Tg(BCL2)36Wehi/0 Tg(IghMyc)22Bri/0 Zfp574em1Btlr/Zfp574em1Btlr
(B6.Cg-Zfp574em1Btlr Tg(BCL2)36Wehi Tg(IghMyc)22Bri)
|
increased leukemia incidence
|
J:354285
|
Tg(BCL2/IGH)#Jcre/0 Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)
|
increased chronic lymphocytic leukemia incidence
|
J:94116
|
Tg(BCR/ABL)623Hkp/0
(involves: C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:160846
|
increased leukemia incidence
|
J:89786
|
Tg(BCR/ABL)623Hkp/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
increased leukemia incidence
|
J:99168
|
Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA)
|
increased leukemia incidence
|
J:76680
|
Tg(CD2-Lmo2)#Thr/0
(involves: C57BL/6 * CBA)
|
increased acute lymphoblastic leukemia incidence
|
J:102058
|
Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
increased leukemia incidence
|
J:93665
|
Tg(CMV-SALL4_iB)#Chai/?
(Not Specified)
|
increased leukemia incidence
|
J:115037
|
Tg(CSTG-NPM1/RARA)#Sjch/0
(involves: C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:55196
|
increased chronic myelocytic leukemia incidence
|
J:55196
|
increased leukemia incidence
|
J:55196
|
Tg(CTSG-NUMA1/RARA)#Skr/0
(involves: C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:88103
|
Tg(CTSG-PML/RARA)135Ley/?
(Not Specified)
|
increased acute promyelocytic leukemia incidence
|
J:77881
|
Tg(CTSG-PML/RARA)135Ley/?
(involves: C3H * C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:59080
|
Tg(CTSG-PML/RARA)135Ley/0 Tg(CTSG-RARA/PML)2544Ley/0
(involves: C3H * C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:59080
|
Tg(CTSG-PML/RARA)135Ley/0 Tg(CTSG-RARA/PML)#Ley/0
(involves: C3H * C57BL/6)
|
increased acute promyelocytic leukemia incidence
|
J:59080
|
Tg(CTSG-PML/RARA)6179Ppp/0
(Not Specified)
|
increased acute promyelocytic leukemia incidence
|
J:40373
|
increased leukemia incidence
|
J:40373
|
Tg(CTSG-PML/RARA)#Ppp/0
(Not Specified)
|
increased acute promyelocytic leukemia incidence
|
J:78201,
J:40373
|
increased leukemia incidence
|
J:78201,
J:40373
|
Tg(CTSG-RARA/ZBTB16)#Ppp/0 Tg(CTSG-ZBTB16/RARA)#Ppp/0
(Not Specified)
|
increased acute promyelocytic leukemia incidence
|
J:65878
|
increased leukemia incidence
|
J:65878
|
Tg(CTSG-RARA/ZBTB16)#Sjch/0 Tg(CTSG-ZBTB16/RARA)#Sjch/0
(Not Specified)
|
increased acute promyelocytic leukemia incidence
|
J:194312
|
Tg(CTSG-ZBTB16/RARA)#Ppp/0
(Not Specified)
|
increased chronic myelocytic leukemia incidence
|
J:65878,
J:78201
|
increased leukemia incidence
|
J:78201
|
Tg(CTSG-ZBTB16/RARA)#Ppp/0 Zbtb16tm1Ppp/Zbtb16tm1Ppp
(involves: 129S1/Sv)
|
increased acute promyelocytic leukemia incidence
|
J:65878
|
Tg(CTSG-ZBTB16/RARA)#Sjch/0
(involves: C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:55196
|
increased leukemia incidence
|
J:55196
|
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA)
|
increased leukemia incidence
|
J:237420
|
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop Tg(tetO-NPM1/ALK,-luc)2Gde/0
(involves: FVB/N)
|
increased leukemia incidence
|
J:160236
|
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop Tg(tetO-TPM3/ALK,-luc)2Gde/0
(involves: FVB/N)
|
increased leukemia incidence
|
J:160236
|
Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr)
|
increased leukemia incidence
|
J:97873,
J:67478
|
Tg(H2-K-Hmga1)#Lmsr/0
(involves: C57BL/6 * SJL)
|
increased leukemia incidence
|
J:121308
|
increased T cell acute lymphoblastic leukemia incidence
|
J:90252
|
Tg(Igh-HMGA2)#Cro/0
(FVB/N-Tg(Igh-HMGA2)#Cro)
|
increased T cell acute lymphoblastic leukemia incidence
|
J:233225
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
increased chronic lymphocytic leukemia incidence
|
J:162077
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0 Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased chronic lymphocytic leukemia incidence
|
J:162077
|
Tg(Igh-ROR1)1Kip/0
(C57BL/6-Tg(Igh-ROR1)1Kip)
|
increased chronic lymphocytic leukemia incidence
|
J:206368
|
Tg(Igh-ROR1)1Kip/0 Tg(Igh-V186.2-TCL1A)3Cro/0
(B6.Cg-Tg(Igh-ROR1)1Kip Tg(Igh-V186.2-TCL1A)3Cro)
|
increased chronic lymphocytic leukemia incidence
|
J:206368
|
Tg(Igh-TCL1A)1Ypek/0
(FVB/N-Tg(Igh-TCL1A)1Ypek)
|
increased chronic lymphocytic leukemia incidence
|
J:160184
|
Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6)
|
increased leukemia incidence
|
J:76574
|
Tg(Igh-V186.2-TCL1A)3Cro/0
(B6.Cg-Tg(Igh-V186.2-TCL1A)3Cro)
|
increased chronic lymphocytic leukemia incidence
|
J:206368
|
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
increased leukemia incidence
|
J:78177
|
Tg(IghMyc)22Bri/0
(B6.Cg-Tg(IghMyc)22Bri/J)
|
increased leukemia incidence
|
J:354285
|
Tg(Kit*D814V)1Roer/0 Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:169611
|
increased leukemia incidence
|
J:169611
|
Tg(Kit*D814V)3Roer/0 Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased leukemia incidence
|
J:169611
|
Tg(Lck-LMO1)11Sjk/0 Tg(STIL-TAL1)A5(3)Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros)
|
increased leukemia incidence
|
J:40868
|
Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2)
|
increased acute lymphoblastic leukemia incidence
|
J:63300
|
Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led)
|
increased leukemia incidence
|
J:36076
|
Tg(Lck-Tax)53Hall/0
(involves: C57BL/6)
|
increased leukemia incidence
|
J:129531
|
Tg(Lck-TNFSF13)3919Mhah/0
(B6.Cg-Tg(Lck-TNFSF13)3919Mhah)
|
increased chronic lymphocytic leukemia incidence
|
J:94628
|
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:144382
|
Tg(Ly6a-BCR/ABL1)IS1AIsg/0 Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA)
|
increased leukemia incidence
|
J:144382
|
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:144382
|
Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg/0
(involves: C57BL/6J * CBA)
|
increased chronic myelocytic leukemia incidence
|
J:144382
|
Tg(Mx1-cre)1Cgn/0 Tg(Tal1-tTA)19Dgt/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0
(involves: C57BL/6 * CBA/J * DBA/2 * FVB/N)
|
increased chronic myelocytic leukemia incidence
|
J:227558
|
Tg(PML-RARA)556Kog/?
(involves: FVB/N)
|
increased acute promyelocytic leukemia incidence
|
J:39327
|
Tg(PML-RARA)556Kog/0
(FVB/N-Tg(PML-RARA)556Kog)
|
increased acute promyelocytic leukemia incidence
|
J:262172
|
Tg(Tcrb-TCF3/PBX1)19Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased acute lymphoblastic leukemia incidence
|
J:95693
|
increased leukemia incidence
|
J:95693
|
Tg(Tcrb-TCF3/PBX1)23Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased acute lymphoblastic leukemia incidence
|
J:95693
|
increased leukemia incidence
|
J:95693
|
Tg(tetO-BCR/ABL1)2Dgt/0 Tg(MMTVtTA)1Mam/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased leukemia incidence
|
J:72377
|
Tg(tetO-BCR/ABL1)27Dgt/0 Tg(MMTVtTA)1Mam/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased leukemia incidence
|
J:72377
|
Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy)
|
increased acute myeloid leukemia incidence
|
J:257690
|
Tg(Vav1-ERG)#Jpim/0
(involves: C57BL/6)
|
increased acute lymphoblastic leukemia incidence
|
J:203438,
J:174808
|
increased leukemia incidence
|
J:203438,
J:174808
|
Tg(Vav1-NUP98/HOXD13)C1Apla/0
(FVB/N-Tg(Vav1-NUP98/HOXD13)C1Apla)
|
increased leukemia incidence
|
J:107446
|
Tg(Vav1-NUP98/HOXD13)G2Apla/0
(C57BL/6-Tg(Vav1-NUP98/HOXD13)G2Apla)
|
increased leukemia incidence
|
J:107446
|
Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat)
|
increased leukemia incidence
|
J:257519
|
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
increased leukemia incidence
|
J:82331
|
Trp53Bbl/Trp53Bbl
(C57BL/6JSfdAnu-Trp53Bbl/Anu)
|
increased leukemia incidence
|
J:104190
|
Trp53bhy/Trp53bhy
(C57BL/6JSfdAnu-Trp53bhy/Anu)
|
increased leukemia incidence
|
J:104190
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased leukemia incidence
|
J:135509
|
Trp53tm1Tyj/Trp53+ Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:98958
|
Trp53tm1Tyj/Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased leukemia incidence
|
J:228632
|
Trp63tm1Fmc/Trp63+ Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:98958
|
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J)
|
increased leukemia incidence
|
J:119985
|
Zfand2btm1Otin/Zfand2btm1Otin
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased chronic myelocytic leukemia incidence
|
J:233169
|
Zfp36l1tm1.1Tnr/Zfp36l1tm1.1Tnr Zfp36l2tm1.1Tnr/Zfp36l2tm1.1Tnr Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL)
|
increased leukemia incidence
|
J:162388
|